E10.352
Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula
Clinical Classification Guidelines
Medical Intelligence & Overview
Type 1 diabetes mellitus is a chronic health condition where the body's immune system mistakenly attacks insulin-producing cells in the pancreas. This results in the body's inability to produce enough insulin, a hormone necessary for managing blood sugar levels. Over time, high blood sugar can cause various complications, including damage to the eyes. One such serious eye complication is proliferative diabetic retinopathy, a condition characterized by abnormal blood vessel growth on the retina. When proliferative diabetic retinopathy worsens, it can lead to a traction retinal detachment involving the macula, threatening vision. The ICD-10 code E10.352 specifically refers to this advanced eye complication associated with Type 1 diabetes.
Causes & Symptoms
Clinical Causes: Persistent high blood sugar levels due to inadequate management of Type 1 diabetes Chronic damage to retinal blood vessels caused by diabetes-related blood vessel changes Formation of new, fragile blood vessels that grow on the surface of the retina (neovascularization)
Key Symptoms: Sudden or gradual loss of vision Seeing floaters or spots in the visual field Blurred vision, especially when the traction causes retinal detachment Distorted vision, where straight lines appear bent or curved In some cases, no noticeable symptoms until significant vision loss occurs
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves comprehensive eye examinations, including dilated fundus exams to visualize the retina. Additional imaging tests such as optical coherence tomography (OCT) and fluorescein angiography help assess the extent of retinal damage, blood vessel growth, and detachment. Regular eye check-ups are essential for individuals with Type 1 diabetes to detect diabetic retinopathy early and prevent severe complications.
Treatment Protocols: Treatment options aim to halt or slow the progression of proliferative diabetic retinopathy and manage retinal detachment. These may include: - **Laser therapy (panretinal photocoagulation)**: To reduce abnormal blood vessel growth and prevent further bleeding - **Anti-VEGF injections**: Medications that inhibit vascular endothelial growth factor, thereby decreasing neovascularization - **Vitrectomy surgery**: An invasive procedure to remove the vitreous gel and repair retinal detachment involving the macula - **Management of blood sugar levels**: Tight control of blood glucose to prevent further vascular damage Proactive management and regular monitoring are crucial to preserving vision and preventing permanent eye damage.
Clinical Advice & FAQs
Billing Guidance
Is E10.352 a billable ICD-10 code?
Yes, E10.352 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E10.352?
Clinical documentation must specify the nature of Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula and any associated comorbidities for accurate reporting.
Cite this Clinical Reference